首頁 > 市場調查報告書 > 醫療設備

體外診斷癌症癌症診斷

市場調查報告書

商品編碼

2075172

肺癌診斷和篩檢市場：按檢測類型、癌症類型、最終用戶和地區分類。

Lung Cancer Diagnostic and Screening Market, By Test Type, By Cancer Type, By End User, By Geography

出版日期: 2026年04月29日 | 出版商:

Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到2026年，肺癌診斷和篩檢市場規模將達到32.878億美元，到2033年將達到65.304億美元。預計從2026年到2033年，該市場將以10.3%的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	32.878億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	10.30%	2033年市場規模預測：	65.304億美元

肺癌起源於肺部，並可轉移至身體其他器官，如淋巴結和腦部。反之，其他器官的癌症也可能轉移至肺部。癌細胞從一個器官擴散到另一個器官的過程稱為「轉移」。肺癌通常分為兩大類：小細胞肺癌和非小細胞肺癌。這兩種肺癌的生長方式不同，所需的治療方法也不同。根據美國癌症協會統計，非小細胞肺癌比小細胞肺癌更常見。肺癌的症狀因人而異。有些人會出現與肺部相關的症狀，而有些人，由於肺癌已擴散至身體其他部位（發生轉移），可能會出現這些部位特有的症狀。肺癌的症狀包括咳嗽加劇或持續、胸痛、呼吸急促、喘息、咳血、持續疲勞和不明原因的體重減輕。

根據美國疾病管制與預防中心（CDC）的數據，肺癌是美國第三大常見癌症。在美國，死於肺癌的人數超過其他任何癌症。例如，美國癌症協會估計，2018年有154,050名美國人死於肺癌，約佔所有癌症死亡人數的25%。醫生可能會進行多種檢查來確診肺癌，包括生物標記檢測、影像檢查和切片檢查。

市場動態

在預測期內，監管部門的批准和新篩檢測試的市場推廣預計將推動全球肺癌診斷和篩檢市場的成長。例如，2020年8月，美國食品藥物管理局（FDA）批准了一種液體活體組織切片伴隨診斷試劑盒，該試劑盒也採用了次世代定序（NGS）技術，用於識別攜帶表皮液態生物檢體因子受體（EGFR）基因特定突變的高致死性轉移性非小細胞肺癌（NSCLC）患者。

然而，篩檢的高成本預計也將是限制市場成長的因素之一。例如，根據美國國際醫學研究委員會（ABIM）的數據，電腦斷層掃描的費用超過300美元。而且，這項檢查需要定期進行。

本研究的主要特點：

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據以下參數對全球肺癌診斷和篩檢市場的主要參與者進行了分析：公司概況、財務表現、產品系列、企業發展區域、分銷策略、關鍵發展和策略。
本報告提供的見解將使企業負責人和經營團隊能夠就未來的產品發布、政府措施、技術升級、市場擴張和行銷策略做出明智的決策。
這份「全球肺癌診斷和篩檢市場」報告的目標受眾是業內眾多相關人員，包括投資者、產品製造商、經銷商、供應商、研究和諮詢公司、新參與企業和金融分析師。

北美洲
- 美國
- 加拿大
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第8章競爭情勢

公司簡介
- Abbott
- Amgen Inc.,
- Illumina, Inc.
- Thermo Fisher Scientific Inc.
- Lepu Medical Technology（Beijing）Co.,Ltd.
- AstraZeneca
- F. Hoffmann-La Roche Ltd
- Laboratory Corporation of America Holdings.
- Agilent Technologies, Inc.
- QIAGEN
- Quest Diagnostics Incorporated.
- NeoGenomics Laboratories.
- Myriad Genetics, Inc.
- GRAIL, LLC.
- DELFI Diagnostics

第9章

參考
調查方法

簡介目錄

Product Code: CMI4434

Lung Cancer Diagnostic And Screening Market is estimated to be valued at USD 3,287.8 Mn in 2026 and is expected to reach USD 6,530.4 Mn by 2033, growing at a compound annual growth rate (CAGR) of 10.3% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 3,287.8 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	10.30%	2033 Value Projection:	USD 6,530.4 Mn

Lung cancer begins in the lungs and may spread to lymph nodes or other organs in the body, such as the brain. Cancer from other organs also may spread to the lungs. When cancer cells spread from one organ to another, they are called metastases. Lung cancers usually are grouped into two main types such as small cell and non-small cell. These types of lung cancer grow differently and are treated differently. According American Cancer Society non-small cell lung cancer is more common than small cell lung cancer. Different people have different symptoms for lung cancer. Some people have symptoms related to the lungs. Some people whose lung cancer has spread to other parts of the body (metastasized) have symptoms specific to that part of the body. Lung cancer symptoms may include coughing that gets worse or prolonged coughing, chest pain, shortness of breath, wheezing, coughing of blood, feeling very tired all the time, weight loss with no known cause.

According to the Centers for Disease Control and Prevention, lung cancer is the third most common cancer in the U.S. Most people in the U.S. die from lung cancer than any other type of cancer. For instance, According American Cancer Society, an estimated 154,050 Americans were expected to die from lung cancer in 2018, accounting for approximately 25% of all cancer deaths. Doctors may perform several tests to confirm lung cancer such as biomarker test, imaging test, and biopsy.

Market Dynamics

Regulatory approvals and launches of new screening test are expected to propel growth of the global lung cancer diagnostic and screening market during the forecast period. For instance, in August 2020, the U.S. Food and Drug Administration approved the liquid biopsy companion diagnostic that also uses next-generation sequencing (NGS) technology to identify patients with specific types of mutations of the epidermal growth factor receptor (EGFR) gene in a deadly form of metastatic non-small cell lung cancer (NSCLC).

However, high cost of lung cancer screening test is also expected to limit the market growth. For instance, according to the American Board of International medicine a CT scan costs US$ 300 and more. These test one need to take periodically.

Key features of the study:

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by leading players
It profiles key players in the global lung cancer diagnostic and screening market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key players covered as a part of this study include Abbott, Illumina, Inc, Thermo Fischer Scientific, QIAGEN, Quest Diagnostics Incorporated, NeoGenomics, NanoString, Myriad Genetics, Inc. F. Hoffmann-La Roche Ltd., Danaher, Agilent Technologies, Inc., AstraZeneca, Sanofi, and Janssen Pharmaceuticals, Inc.
Insights from this report would allow marketers and management authorities of companies to make informed decisions with respect to future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
The global lung cancer diagnostic and screening market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for lung cancer diagnostic and screening market, research and consulting firms, new entrants, and financial analysts.

Detailed Segmentation:

Global Lung Cancer Diagnostic and Screening market, By Test Type (Revenue, USD Mn, 2021 - 2033)
Biomarkers Tests
- EGFR Mutation Test
- KRAS Mutation Test
- ALK Test
- HER2 Test
- Others
Imaging Tests
- Computed Tomography (CT) Scan
- Positron Emission Tomography (PET) Scan
- Chest X-RAY
- Others
Biopsy
- Needle Biopsy
- Bronchoscopy Biopsy
- Open Biopsy
- Others
Global Lung Cancer Diagnostic and Screening Market, By Cancer Type (Revenue, USD Mn, 2021 - 2033)
Non-small cell lung cancer
Small Cell Lung Cancer
Global Lung Cancer Diagnostic and Screening Market, By End User (Revenue, USD Mn, 2021 - 2033)
Hospital Associated Labs
Independent Diagnostic Laboratories
Diagnostic Imaging Centers
Cancer Research Institutes
Global Lung Cancer Diagnostic and Screening Market, By Region (Revenue, USD Mn, 2021 - 2033)
North America
- By Country:
  - U.S.
  - Canada
- By Test Type:
  - Biomarkers Tests
  - Imaging Tests
  - Biopsy
- By Cancer Type:
  - Non-small cell lung cancer
  - Small Cell Lung Cancer
- By End User:
  - Hospitals
  - Independent Diagnostic Laboratories
  - Diagnostic Imaging Centers
  - Cancer Research Institutes
Europe
- By Country:
  - U.K.
  - Germany
  - Italy
  - Spain
  - France
  - Russia
  - Rest of Europe
- By Test Type:
  - Biomarkers Tests
  - Imaging Tests
  - Biopsy
- By Cancer Type:
  - Non-small cell lung cancer
  - Small Cell Lung Cancer
- By End User:
  - Hospitals
  - Independent Diagnostic Laboratories
  - Diagnostic Imaging Centers
  - Cancer Research Institutes
Asia Pacific
- By Country:
  - Australia
  - India
  - China
  - Japan
  - ASEAN
  - South Korea
  - Rest of Asia Pacific
- By Test Type:
  - Biomarkers Tests
  - Imaging Tests
  - Biopsy
- By Cancer Type:
  - Non-small cell lung cancer
  - Small Cell Lung Cancer
- By End User:
  - Hospitals
  - Independent Diagnostic Laboratories
  - Diagnostic Imaging Centers
  - Cancer Research Institutes
Latin America
- By Country:
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
- By Test Type:
  - Biomarkers Tests
  - Imaging Tests
  - Biopsy
- By Cancer Type:
  - Non-small cell lung cancer
  - Small Cell Lung Cancer
- By End User:
  - Hospitals
  - Independent Diagnostic Laboratories
  - Diagnostic Imaging Centers
  - Cancer Research Institutes
Middle East
- By Country:
  - GCC
  - Israel
  - Rest of Middle East
- By Test Type:
  - Biomarkers Tests
  - Imaging Tests
  - Biopsy
- By Cancer Type:
  - Non-small cell lung cancer
  - Small Cell Lung Cancer
- By End User:
  - Hospitals
  - Independent Diagnostic Laboratories
  - Diagnostic Imaging Centers
  - Cancer Research Institutes
Africa
- By Country/Region:
  - South Africa
  - Central Africa
  - North Africa
- By Test Type:
  - Biomarkers Tests
  - Imaging Tests
  - Biopsy
- By Cancer Type:
  - Non-small cell lung cancer
  - Small Cell Lung Cancer
- By End User:
  - Hospitals
  - Independent Diagnostic Laboratories
  - Diagnostic Imaging Centers
  - Cancer Research Institutes
Company Profiles
Abbott
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
Illumina, Inc
Thermo Fischer Scientific
QIAGEN
Quest Diagnostics Incorporated
NeoGenomics
NanoString
Myriad Genetics, Inc.
Hoffmann-La Roche Ltd
Danaher
Agilent Technologies, Inc.
AstraZeneca
Sanofi
Janssen Pharmaceuticals, Inc.

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Test Type
- Market Snippet, By Cancer Type
- Market Snippet, By End User
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Recent Test Launches
Epidemiology
Merger, Acquisition, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis

4. Global Lung Cancer Diagnostic and Screening Market, By Test Type, 2021-2033, (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Biomarkers Test
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Mn)
- Segment Trends
  - EGFR Mutation Test
  - KRAS Mutation Test
  - ALK Test
  - HER2 Test
  - Others
Imaging Test
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Mn)
- Segment Trends
  - Computed Tomography (CT) scan
  - Positron Emission Tomography (PET) scan
  - Chest X-Ray
  - Others
Biopsy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Mn)
- Segment Trends

5. Global Lung Cancer Diagnostic and Screening Market, By Cancer Type, 2021-2033, (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Non-small cell lung cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Mn)
- Segment Trends
Small Cell Lung Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Mn)
- Segment Trends

6. Global Lung Cancer Diagnostic and Screening Market, By End User, 2021-2033, (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Hospital Associated Labs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Mn)
Independent Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Mn)
Cancer Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Mn)

7. Global Lung Cancer Diagnostic and Screening Market, By Region, 2021-2033, (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
North America
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Test Type, 2021 -2033, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Cancer Type, 2021 -2033, (US$ Mn)
- Market Size and Forecast,Y-o-Y Growth and By End User, 2021-2033, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 -2033, (US$ Mn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Test Type, 2021 -2033, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Cancer Type, 2021 -2033, (US$ Mn)
- Market Size and Forecast,Y-o-Y Growth and By End User, 2021-2033, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 -2033, (US$ Mn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Test Type, 2021 -2033, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Cancer Type, 2021 -2033, (US$ Mn)
- Market Size and Forecast,Y-o-Y Growth and By End User, 2021-2033, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 -2033, (US$ Mn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Test Type, 2021 -2033, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Cancer Type, 2021 -2033, (US$ Mn)
- Market Size and Forecast,Y-o-Y Growth and By End User, 2021-2033, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 -2033, (US$ Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Test Type, 2021 -2033, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Cancer Type, 2021 -2033, (US$ Mn)
- Market Size and Forecast,Y-o-Y Growth and By End User, 2021-2033, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 -2033, (US$ Mn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Test Type, 2021 -2033, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Cancer Type, 2021 -2033, (US$ Mn)
- Market Size and Forecast,Y-o-Y Growth and By End User, 2021-2033, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 -2033, (US$ Mn)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

Company Profiles
- Abbott
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Amgen Inc.,
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Illumina, Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Thermo Fisher Scientific Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Lepu Medical Technology(Beijing)Co.,Ltd.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- AstraZeneca
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- F. Hoffmann-La Roche Ltd
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Laboratory Corporation of America Holdings.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Agilent Technologies, Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- QIAGEN
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Quest Diagnostics Incorporated.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- NeoGenomics Laboratories.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Myriad Genetics, Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- GRAIL, LLC.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- DELFI Diagnostics
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies

9. Section

References
Research Methodology
About us and Sales Contact

02-2729-4219

+886-2-2729-4219

License/價格

相關商品

肺癌診斷市場－全球產業規模、佔有率、趨勢、機會和預測，按類型、檢測方法、地區和競爭格局分類，2020-2030年預測

肺癌診斷市場報告：趨勢、預測和競爭分析（至2031年）

2025年肺癌診斷與篩檢全球市場報告

肺癌診斷市場規模、佔有率和趨勢分析報告：按類型、測試、最終用途、地區和細分市場預測，2025-2033 年

肺癌診斷市場，診斷測試類型 - 全球產業分析、規模、佔有率、成長、趨勢和預測，2024-2034 年

FAQ

肺癌診斷和篩檢市場：按檢測類型、癌症類型、最終用戶和地區分類。